Giuseppe Locatelli

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Integrated proteogenomic profiling reveals coordinated differential expression signatures during neuroinflammation.

Integrated proteogenomic profiling reveals coordinated differential expression signatures during neuroinflammation.

Journal: Acta neuropathologica communications

Published: May 13, 2026

Lost in translation: rethinking animal models of progressive MS (an industry perspective).

Lost in translation: rethinking animal models of progressive MS (an industry perspective).

Journal: Multiple sclerosis and related disorders

Published: May 30, 2025

Deep learning-driven MRI for accurate brain volumetry in murine models of neurodegenerative diseases.

Deep learning-driven MRI for accurate brain volumetry in murine models of neurodegenerative diseases.

Journal: Frontiers in neuroscience

Published: May 20, 2025

A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors.

A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 08, 2025

Role of CSF flow and meningeal barriers in the development of inflammatory lesions at the CNS-PNS transition zone of cranial nerves in autoimmune demyelinating diseases.

Role of CSF flow and meningeal barriers in the development of inflammatory lesions at the CNS-PNS transition zone of cranial nerves in autoimmune demyelinating diseases.

Journal: Acta neuropathologica

Published: April 11, 2025

Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib.

Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib.

Journal: Clinical pharmacology and therapeutics

Published: December 18, 2024

Experimental autoimmune encephalomyelitis causes skeletal muscle dysfunction in mice.

Experimental autoimmune encephalomyelitis causes skeletal muscle dysfunction in mice.

Journal: Frontiers in neurology

Published: November 22, 2024

The therapeutic potential of exercise for improving mobility in multiple sclerosis.

The therapeutic potential of exercise for improving mobility in multiple sclerosis.

Journal: Frontiers in physiology

Published: August 08, 2024

Impairment of spinal CSF flow precedes immune cell infiltration in an active EAE model.

Impairment of spinal CSF flow precedes immune cell infiltration in an active EAE model.

Journal: Journal of neuroinflammation

Published: July 30, 2024

Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities.

Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities.

Journal: Pharmacogenomics

Published: March 21, 2024

Junctional adhesion molecule-A deficient mice are protected from severe experimental autoimmune encephalomyelitis.

Junctional adhesion molecule-A deficient mice are protected from severe experimental autoimmune encephalomyelitis.

Journal: European journal of immunology

Published: September 07, 2023

First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors.

First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 10, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026